McCaskill Demands Explanation for Nostrum’s August Price Hikes

Drug Industry Daily
A A
Sen. Claire McCaskill (D-Mo.) called on Nostrum Pharmaceuticals, a drugmaker with facilities in Kansas City, to explain a reported 400 percent price hike in its bladder infection treatment, nitrofurantoin.

To View This Article:

Login

Subscribe To Drug Industry Daily